Presença de arritmias cardíacas na Síndrome Pós-Covid: revisão de literatura

##plugins.themes.bootstrap3.article.main##

Guilherme Lima Weksler
Eithor Henrique Siqueira
Felipe Lima Weksler
João Vitor Romão Neto Mury de Aquino
Luiz Felipe Alves Fernandes
Gabriel Porto Soares

Resumo

Objetivo: Analisar a literatura buscando compreender melhor a presença de arritmias cardíacas na Síndrome Pós-Covid. Revisão bibliográfica: A prevalência de alterações eletrocardiográficas em pacientes portadores da Covid Longa vem se mostrando elevada. Sendo que a alteração mais comumente encontrada foi a taquicardia sinusal, que parece se apresentar como duas síndromes de mecanismos semelhantes, que são a Síndrome de Taquicardia Postural Ortostática e a Síndrome de Taquicardia Sinusal Inapropriada. A fisiopatologia parece ser o dano causado ao Sistema Nervoso Autônomo, através de uma ativação autoimune que ocorre após a infecção viral. Além disso, outros eventos arrítmicos foram encontrados nesses pacientes, como o desenvolvimento de arritmias atriais e ventriculares associadas a miocardite viral. Considerações finais: Apesar da elevada prevalência e carga sobre a população acometida, existe uma escassez de evidências científicas que buscam compreender os mecanismos arritmogênicos causados pelo SARS-CoV-2. Além disso, é de extrema importância que sejam estabelecidos protocolos que permitam rastreio otimizado desses pacientes, o mais cedo possível.

##plugins.themes.bootstrap3.article.details##

Como Citar
WekslerG. L., SiqueiraE. H., WekslerF. L., AquinoJ. V. R. N. M. de, FernandesL. F. A., & SoaresG. P. (2022). Presença de arritmias cardíacas na Síndrome Pós-Covid: revisão de literatura. Revista Eletrônica Acervo Saúde, 15(10), e11004. https://doi.org/10.25248/reas.e11004.2022
Seção
Revisão Bibliográfica

Referências

1. ABBOUD H, et al. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg, 2020; 140: 49-53.

2. ALI M, et al. Inappropriate sinus tachycardia: a review. Rev Cardiovasc Med, 2021; 22(4):1331-1339.

3. ARANYÓ J, et al. Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep, 2022; 12(1): 298.

4. BEGIENEMAN MP, et al. Ventricular myocarditis coincides with atrial myocarditis in patients. Cardiovasc Pathol, 2016; 25(2): 141-8.

5. BLAGOVA O, et al. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol, 2021; 51(4): 893-902.

6. DAVIS HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 2021; 38: 101019.

7. EVANS RA, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med, 2021; 9(11): 1275-1287.

8. GAWAŁKO M, et al. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc, 2020; 30: 100631.

9. GOLDBERGER J, et al. Autonomic Nervous System Dysfunction: JACC Focus Seminar. J Am Coll Cardiol, 2019; 73(10): 1189-1206.

10. HOFFMANN M, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 2020; 181(2): 271-280.

11. HONARDOOST M, et al. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis. Cerebrovasc Dis, 2021; 50(2): 132-140.

12. HUANG C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 2021; 397(10270): 220-232.

13. INGUL CB, et al. Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19. J Am Heart Assoc, 2022; 11(3): e023473.

14. JOHANSSON M, et al. COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience. JACC Case Rep, 2021; 3(4): 573-580.

15. KITSOU V, et al. Intermittent left bundle branch block with septal flash and postural orthostatic tachycardia syndrome in a young woman with long COVID-19. BMJ Case Rep, 2022; 15(6): e249608.

16. LIU T, et al. Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China. Clin Infect Dis, 2022; 74(11): 1953-1965.

17. MITRANI RD, et al. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm, 2020; 17(11): 1984-1990.

18. MOHAMMAD M, et al. Cardiac arrhythmias associated with COVID-19 infection: state of the art review. Expert Rev Cardiovasc Ther, 2021; 19(10): 881-889.

19. NASCIMENTO JHP, et al. COVID-19 and Myocardial Injury in a Brazilian ICU: High Incidence and Higher Risk of In-Hospital Mortality. Arq Bras Cardiol, 2021; 116(2): 275-282.

20. National Institute for Health and Care Excellence, 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. Disponível em: https://www.nice.org.uk/guidance/ng188. Acessado em: 18 de Agosto de 2022

21. PERETTO G, et al. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. J Am Coll Cardiol, 2020; 75(9): 1046-1057.

22. POLLACK A, et al. Viral myocarditis--diagnosis, treatment options, and current controversies. Nat Rev Cardiol, 2015; 12(11): 670-80.

23. PUNTMANN VO, et al. Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol, 2020; 5(11): 1265-1273.

24. RAMAN B, et al. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J, 2022; 43(11): 1157-1172.

25. REYNBAKH O, et al. Arrhythmia patterns during and after hospitalization for COVID-19 infection detected via patch-based mobile cardiac telemetry. Am Heart J Plus, 2022; 13: 100084.

26. STÅHLBERG M, et al. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. Am J Med, 2021; 134(12): 1451-1456.

27. SIRIPANTHONG B, et al. The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury. JACC Basic Transl Sci, 2022; 7(3): 294-308.

28. SUTHANAR N, et al. From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Curr Heart Fail Rep, 2017; 14(4): 235-250.

29. SWAI J, et al. Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis. BMC Cardiovasc Disord, 2019; 19(1): 320.

30. VERNINO S, STILES LE. Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding. Auton Neurosci, 2018; 215: 78-82.

31. WORLD HEALTH ORGANIZATION (WHO).WHO COVID-19 Dashboard. 2022. World Health Organization, Geneve. Disponível em: https://covid19.who.int/. Acessado em: 16 de Agosto de 2020.

32. YU CM, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J, 2006; 82(964): 140-4.

33. ZYLLA MM, et al. Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19. J Clin Med, 2021; 10(1): 133.